Our mission is to identify and circumvent mechanisms of resistance to cancer immunotherapies and develop the next generation of cancer treatments that benefit every patient.

Crescat scientia, vita excolatur

We use state-of-the-art technology to mechanistically investigate immune responses to cancer using preclinical laboratory modeling and translational studies of human cancer. We also leverage mathematical modeling and artificial intelligence to advance our understanding of tumor-immune interactions. Our goal is to translate findings into clinical trials to improve the efficacy of cancer immunotherapy for patients.

Scroll to Top